{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:55Z","timestamp":1793060035443,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.clinre.2022.101948","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T12:16:50Z","timestamp":1654085810000},"page":"101948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case report"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1349-9501","authenticated-orcid":false,"given":"R.L.","family":"Goetgebuer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.C.","family":"Masclee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"van der Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"van der Woude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clinre.2022.101948_bib0001","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinre.2022.101948_bib0002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gutjnl-2014-307127","article-title":"Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results","volume":"64","author":"Wyant","year":"2015","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.clinre.2022.101948_bib0003","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/apt.16060","article-title":"Long-term safety of vedolizumab for inflammatory bowel disease","volume":"52","author":"Loftus","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.clinre.2022.101948_bib0004","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12328-017-0730-7","article-title":"Asymptomatic acute hepatitis E in a female patient with ulcerative colitis","volume":"10","author":"Suzuki","year":"2017","journal-title":"Clin J Gastroenterol"},{"issue":"5","key":"10.1016\/j.clinre.2022.101948_bib0005","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3201\/eid2405.171845","article-title":"Chronic Genotype 3 Hepatitis E in pregnant woman receiving infliximab and azathioprine","volume":"24","author":"Charre","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.clinre.2022.101948_bib0006","article-title":"Chronic genotype 1 hepatitis E infection from immunosuppression for ileo-colonic Crohn's disease","author":"Robins","year":"2018","journal-title":"Oxf Med Case Rep 2018"},{"issue":"3","key":"10.1016\/j.clinre.2022.101948_bib0007","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.gastrohep.2015.06.004","article-title":"Hepatitis E seroprevalence in inflammatory bowel disease","volume":"39","author":"Senosiain","year":"2016","journal-title":"Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.clinre.2022.101948_bib0008","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.clinre.2022.101948_bib0009","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMc0708687","article-title":"Chronic hepatitis E with cirrhosis in a kidney-transplant recipient","volume":"358","author":"Gerolami","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.clinre.2022.101948_bib0010","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740122000808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740122000808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:32:56Z","timestamp":1761895976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740122000808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2210740122000808"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2022.101948","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case report","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2022.101948","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101948"}}